Global Genitourinary Drugs Market 2019-2023
| Published: Mar 2019 | Pages: 125 | SKU: IRTNTR30954 |
Below are some of the key findings from the genitourinary drugs market analysis report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the report.
Global Genitourinary Drugs Industry Overview
The high prevalence of genitourinary diseases is one of the critical reasons that will drive market growth. Bacterial infections or STDs can cause genitourinary disorders. It also includes various carcinomas such as ovarian cancer, cervical cancer, bladder cancer, and prostate cancer. Age-related ailments such as Alzheimer’s and disorders like diabetes, obesity, and multiple sclerosis are significantly responsible for these conditions. Additionally, there is also a growing incidence of incontinence and interstitial cystitis. This will increase the consumption of these drugs, in turn, driving the genitourinary drugs market size.
Moreover, the advent of biologics and gene therapy will be one of the major trends that will gain traction in the global market. With the unavailability of curable treatments for some of the genitourinary diseases, companies are focusing on introducing novel treatment options such as gene therapy and biological therapies with minimal side-effects. These therapies treat conditions such as polyneuropathy of hereditary transthyretin-mediated amyloidosis. Physicians recommend biologics for the treatment of patients with multiple genitourinary diseases. The emergent of gene therapy and biologics, coupled with the growing prevalence of these diseases will drive genitourinary drugs market growth at a CAGR of almost 3% during the forecast period.
Top companies covered in the genitourinary drugs market research report
The genitourinary drugs market is moderately fragmented. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by companies, the industry analysis report will help clients identify new growth opportunities and design innovative strategies to improve their market share.
The report offers a complete analysis of various companies including:
- Astellas Pharma Inc.
- AstraZeneca
- Eli Lilly and Company
- Johnson & Johnson Services, Inc.
- Novartis AG
Genitourinary drugs market segmentation based on geographic regions
- Asia
- Europe
- North America
- ROW
North America will account for the highest market share throughout the forecast period. The increased genitourinary diseases, increasing prevalence of STDs, the rise in geriatric population, and new research activities to develop treatment methods are significant factors for the high growth of the genitourinary drugs market in the region.
Genitourinary drugs market segmentation based on the type
- Genital diseases
- Urinary diseases
The genital diseases segment will account for the highest genitourinary drugs market share because of the growing prevalence of genital diseases such as primary and secondary syphilis cases and considered as the first choice of treatment for many genital diseases. The report provides an accurate prediction of the contribution of all the segments to the growth of the genitourinary drugs market size.
Key highlights of the global genitourinary drugs market for the forecast years 2019-2023:
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the genitourinary drugs market during the next five years
- Precise estimation of the global genitourinary drugs market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the industry across various geographies such as Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details on factors that will challenge the growth of drugs companies
We can help! Our analysts can customize the market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
- Comparison by type
- Genital diseases - Market size and forecast 2018-2023
- Urinary diseases - Market size and forecast 2018-2023
- Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Astellas Pharma Inc.
- AstraZeneca
- Eli Lilly and Company
- Johnson & Johnson Services, Inc.
- Novartis AG
PART 15: APPENDIX
- Research methodology
- List of abbreviations
PART 16: EXPLORE TECHNAVIO
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis